Technical Analysis for BRTX - BioRestorative Therapies, Inc.

Grade Last Price % Change Price Change
D 5.36 6.77% 0.34
BRTX closed up 6.77 percent on Tuesday, December 7, 2021, on 58 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical BRTX trend table...

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 6.77%
Hot IPO Pullback Bullish Swing Setup 6.77%
Calm After Storm Range Contraction 6.77%
Narrow Range Bar Range Contraction 6.77%
NR7 Range Contraction 6.77%
New 52 Week Low Weakness 6.77%
Older End-of-Day Signals for BRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 13 hours ago
10 DMA Resistance about 13 hours ago
Up 10% about 13 hours ago
Up 1 ATR about 13 hours ago
Hot IPO Pullback Entry about 16 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioRestorative Therapies, Inc. Description

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100 that has completed Phase 1 clinical trials is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate, which is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue (BAT). In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Stem Cells Cell Biology Therapeutic Products Cell Therapy Obesity Regenerative Medicine Metabolic Disorders Adult Stem Cell Mesenchymal Stem Cell Shimon Slavin Stem Cell Therapy Non Surgical Treatment

Is BRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.9
52 Week Low 4.911
Average Volume 306,399
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 6.41
10-Day Moving Average 5.73
Average True Range 0.77
ADX 0.0
+DI 15.81
-DI 21.28
Chandelier Exit (Long, 3 ATRs) 6.60
Chandelier Exit (Short, 3 ATRs) 7.21
Upper Bollinger Bands 8.01
Lower Bollinger Band 4.80
Percent B (%b) 0.17
BandWidth 50.14
MACD Line -0.61
MACD Signal Line -0.40
MACD Histogram -0.2102
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.71
Resistance 3 (R3) 6.73 6.30 6.49
Resistance 2 (R2) 6.30 5.96 6.29 6.41
Resistance 1 (R1) 5.83 5.74 6.07 5.81 6.33
Pivot Point 5.40 5.40 5.52 5.39 5.40
Support 1 (S1) 4.93 5.06 5.17 4.91 4.39
Support 2 (S2) 4.50 4.84 4.49 4.31
Support 3 (S3) 4.03 4.50 4.24
Support 4 (S4) 4.01